Johnson & Johnson to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
Johnson & Johnson (NYSE: JNJ) is set to participate in the Morgan Stanley 22nd Annual Global Healthcare Conference on September 4th at the New York Marriott Marquis. Joaquin Duato, Chairman and CEO, and John Reed, Executive VP of Innovative Medicine R&D, will represent the company in a session scheduled for 10:45 am ET.
A live audio webcast of the session will be available on Johnson & Johnson's investor website. Investors and interested parties can access the webcast at www.investor.jnj.com. An audio replay will be available approximately 48 hours after the event.
Johnson & Johnson (NYSE: JNJ) parteciperà alla 22ª Conferenza Globale sulla Salute di Morgan Stanley il 4 settembre presso il New York Marriott Marquis. Joaquin Duato, Presidente e CEO, e John Reed, VP Esecutivo di Innovazione R&D, rappresenteranno l'azienda in una sessione programmata per le 10:45 am ET.
Un webcast audio dal vivo della sessione sarà disponibile sul sito web per investitori di Johnson & Johnson. Gli investitori e tutte le parti interessate potranno accedere al webcast su www.investor.jnj.com. Una registrazione audio sarà disponibile circa 48 ore dopo l'evento.
Johnson & Johnson (NYSE: JNJ) participará en la 22ª Conferencia Anual Global de Salud de Morgan Stanley el 4 de septiembre en el New York Marriott Marquis. Joaquin Duato, Presidente y CEO, y John Reed, VP Ejecutivo de I+D de Medicina Innovadora, representarán a la empresa en una sesión programada para las 10:45 am ET.
Se podrá acceder a un streaming de audio en vivo de la sesión en el sitio web de inversores de Johnson & Johnson. Los inversores y partes interesadas podrán acceder al streaming en www.investor.jnj.com. Una repetición de audio estará disponible aproximadamente 48 horas después del evento.
존슨 앤 존슨 (NYSE: JNJ)은 모건 스탠리 제22회 연례 글로벌 헬스케어 컨퍼런스에 참여할 예정이며, 9월 4일 뉴욕 메리어트 마퀴스에서 개최됩니다. 호아킨 두아토 회장 겸 CEO와 존 리드 혁신 의약품 R&D 부사장이 오전 10:45 ET에 예정된 세션에서 회사를 대표합니다.
세션의 실시간 오디오 웹캐스트는 존슨 앤 존슨의 투자자 웹사이트에서 제공됩니다. 투자자와 관련 당사자는 www.investor.jnj.com에서 웹캐스트에 접근할 수 있습니다. 오디오 재생은 이벤트 48시간 후에 제공될 예정입니다.
Johnson & Johnson (NYSE: JNJ) participera à la 22e Conférence Mondiale Annuelle sur la Santé de Morgan Stanley le 4 septembre au New York Marriott Marquis. Joaquin Duato, Président et CEO, ainsi que John Reed, VP Exécutif de la R&D en Médecine Innovante, représenteront l'entreprise lors d'une session prévue à 10h45 ET.
Un webinaire audio en direct de la session sera disponible sur le site des investisseurs de Johnson & Johnson. Les investisseurs et les parties intéressées pourront accéder au webinaire à l'adresse www.investor.jnj.com. Un enregistrement audio sera disponible environ 48 heures après l'événement.
Johnson & Johnson (NYSE: JNJ) wird an der 22. jährlichen globalen Gesundheitskonferenz von Morgan Stanley am 4. September im New York Marriott Marquis teilnehmen. Joaquin Duato, Vorsitzender und CEO, sowie John Reed, Executive VP für Innovative Medizin F&E, werden das Unternehmen in einer für 10:45 Uhr ET geplanten Sitzung vertreten.
Ein live Audio-Webcast der Sitzung wird auf der Investorenseite von Johnson & Johnson verfügbar sein. Investoren und Interessierte können auf den Webcast unter www.investor.jnj.com zugreifen. Ein Audio-Replay wird etwa 48 Stunden nach der Veranstaltung verfügbar sein.
- None.
- None.
This live audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.
The audio webcast replay will be available approximately 48-hrs after the webcast.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240723451320/en/
Media contact:
media-relations@its.jnj.com
Investor contact:
investor-relations@its.jnj.com
Source: Johnson & Johnson
FAQ
When is Johnson & Johnson (JNJ) participating in the Morgan Stanley Healthcare Conference?
Who will represent Johnson & Johnson (JNJ) at the Morgan Stanley Healthcare Conference?
What time is Johnson & Johnson's (JNJ) session at the Morgan Stanley Healthcare Conference?
How can investors access Johnson & Johnson's (JNJ) session at the Morgan Stanley Healthcare Conference?
When will the replay of Johnson & Johnson's (JNJ) session at the Morgan Stanley Healthcare Conference be available?
